2026 ACC/AHA multisociety guideline on the management of dyslipidemia

Blumenthal, Morris and the writing committee, Circulation and JACC 2026. Retires the 2018 blood cholesterol guideline; scope now explicitly includes hypertriglyceridemia and elevated lipoprotein(a); moves the US toward universal once-in-a-lifetime Lp(a) measurement and its use as a risk enhancer, in line with the NLA 2024 update. Leslie Cho's top-10 talk (Video) is the fastest orientation.